Matlantis CSP has already produced early results across multiple systems—oxides, alloys, and phosphides—discovering more than 10 previously unknown stable crystals. In the Ga–Au–Ca system, it ...
Redwire’s space biotech capabilities are creating valuable opportunities for the biopharma industry as microgravity allows for outcomes that aren’t possible on Earth, including bioprinting materials ...
Microgravity experiments on the International Space Station helped Merck develop a faster subcutaneous version of Keytruda (pembrolizumab). This new injection cuts treatment time to minutes, improving ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a leader in space infrastructure for the next generation space economy, announced today that it has successfully 3D bioprinted the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results